Bio-Techne Corporation's CEO to Speak at J.P. Morgan Healthcare Conference 2025
Bio-Techne Corporation, recognized for its innovative contributions to the life sciences sector, has announced that its President and Chief Executive Officer, Kim Kelderman, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference scheduled for January 14, 2025. This year's conference will occur at 10:30 a.m. PST and is regarded as a pivotal event for networking and showcasing advancements in healthcare.
The J.P. Morgan Healthcare Conference stands out as a premier platform that draws attention from industry leaders, investors, and media, making it an essential event for networking and discussion around the future of healthcare. Bio-Techne's participation reinforces its commitment to the industry and highlights the importance of innovative solutions in medical research and healthcare.
During the presentation, attendees can expect valuable insights into the company's cutting-edge products and services that are vital for both research and clinical diagnostics. Bio-Techne has an extensive portfolio of offerings designed to assist with scientific investigations into biological processes and medical conditions. With approximately 1.2 billion in net sales reported for fiscal 2024, the company's impact on drug discovery and clinical diagnostics is significant.
In addition to Kim Kelderman’s presentation, Bio-Techne encourages interested parties to access a live webcast of the event, which will be available on their Investor Relations page. This initiative demonstrates Bio-Techne’s transparency and commitment to keeping stakeholders informed about its corporate endeavors and the innovative solutions it brings to the healthcare sector.
Bio-Techne Corporation not only operates in the life sciences field but also employs around 3,100 individuals worldwide, showcasing its significant role in the industry. Their products are pivotal as they help in the exploration of specific diseases and aid in developing accurate diagnostic tests, contributing to improved clinical outcomes.
For further engagement and updates, users can check out Bio-Techne’s social media channels or visit their official website, which offers a wealth of information about their latest innovations and research contributions. This upcoming conference appearance is anticipated to stimulate discussions on future collaborations and advancements, emphasizing Bio-Techne's leading role in biotechnological innovation. With a commitment to the healthcare community, Bio-Techne’s presence at this prestigious conference is not only a highlight for the company but also a notable moment for the advancement of healthcare solutions.
Stay connected with Bio-Techne, and don’t miss the live presentation next January, where industry insights and innovations will be front and center, shaping the future of healthcare advancements.
The J.P. Morgan Healthcare Conference stands out as a premier platform that draws attention from industry leaders, investors, and media, making it an essential event for networking and discussion around the future of healthcare. Bio-Techne's participation reinforces its commitment to the industry and highlights the importance of innovative solutions in medical research and healthcare.
During the presentation, attendees can expect valuable insights into the company's cutting-edge products and services that are vital for both research and clinical diagnostics. Bio-Techne has an extensive portfolio of offerings designed to assist with scientific investigations into biological processes and medical conditions. With approximately 1.2 billion in net sales reported for fiscal 2024, the company's impact on drug discovery and clinical diagnostics is significant.
In addition to Kim Kelderman’s presentation, Bio-Techne encourages interested parties to access a live webcast of the event, which will be available on their Investor Relations page. This initiative demonstrates Bio-Techne’s transparency and commitment to keeping stakeholders informed about its corporate endeavors and the innovative solutions it brings to the healthcare sector.
Bio-Techne Corporation not only operates in the life sciences field but also employs around 3,100 individuals worldwide, showcasing its significant role in the industry. Their products are pivotal as they help in the exploration of specific diseases and aid in developing accurate diagnostic tests, contributing to improved clinical outcomes.
For further engagement and updates, users can check out Bio-Techne’s social media channels or visit their official website, which offers a wealth of information about their latest innovations and research contributions. This upcoming conference appearance is anticipated to stimulate discussions on future collaborations and advancements, emphasizing Bio-Techne's leading role in biotechnological innovation. With a commitment to the healthcare community, Bio-Techne’s presence at this prestigious conference is not only a highlight for the company but also a notable moment for the advancement of healthcare solutions.
Stay connected with Bio-Techne, and don’t miss the live presentation next January, where industry insights and innovations will be front and center, shaping the future of healthcare advancements.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.